Connecticut Children's Medical Center

191 Post Road West in Westport Sold After a Brief 22-Month Ownership.

Retrieved on: 
Thursday, August 24, 2023

Together with its partners, Targeted Real Estate Equities LLC (“Targeted”) have closed on the sale of 191 Post Road West, a 31,500+ square foot office building in Westport, CT.

Key Points: 
  • Together with its partners, Targeted Real Estate Equities LLC (“Targeted”) have closed on the sale of 191 Post Road West, a 31,500+ square foot office building in Westport, CT.
    “We were able to execute our strategy earlier than expected thanks to an expansion by Connecticut Childrens Medical Center (“CCMC”) into the remainder of the Property.
  • They will now occupy the entire building on a long-term lease,” said Daniel Steinberg, Managing Director.
  • CCMC is using the space as a children’s specialty care center, their flagship in Fairfield County, offering a wide variety of specialties.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20230824816074/en/

Global Medical Tent Market Outlook and Forecast 2023 - 2028: Growing Military Activities and Increasing Rescue Operations Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 4, 2023

The use of inflatable medical tents is rising in the military, owing to troops stationed worldwide and increasing military investments.

Key Points: 
  • The use of inflatable medical tents is rising in the military, owing to troops stationed worldwide and increasing military investments.
  • The global medical tent market is expected to rise considerably due to increased usage of tents in the military segment, medical emergencies, and rescue operations.
  • The global medical tent market is moderately competitive and is expected to offer significant growth opportunities for vendors during the forecast period.
  • Some key market participants operating in the global medical tent market include Liri Structure, Instent Industries, ZINGERLE GROUP, LANCO, and HDT Global.

Demand for Breastfeeding Support Drives Growth of Nest Collaborative Telehealth Platform

Retrieved on: 
Wednesday, February 8, 2023

In 2022 Nest Collaborative built significantly upon its market-leading presence as the lactation consultation network of choice for health systems and employers.

Key Points: 
  • In 2022 Nest Collaborative built significantly upon its market-leading presence as the lactation consultation network of choice for health systems and employers.
  • "In our experience, parents who receive active support and guidance are more likely to initiate and continue breastfeeding than those who face difficulties alone."
  • Every family should have access to lactation consultants free from friction," said Judith Nowlin, CEO of Nest Collaborative.
  • Nest Collaborative provides unlimited appointments with IBCLCs for parents in need of breastfeeding support.

Nest Collaborative Teams with Connecticut Children's Care Network to Provide Telehealth Breastfeeding Support to Families Across Connecticut

Retrieved on: 
Thursday, January 5, 2023

FARMINGTON, Conn., Jan. 5, 2023 /PRNewswire/ -- Nest Collaborative , the nation's first and largest virtual lactation consultation platform, announced a collaboration with Connecticut Children's Care Network to bring pre- and perinatal breastfeeding support via telehealth to more than 5,000 Connecticut families and newborns.

Key Points: 
  • FARMINGTON, Conn., Jan. 5, 2023 /PRNewswire/ -- Nest Collaborative , the nation's first and largest virtual lactation consultation platform, announced a collaboration with Connecticut Children's Care Network to bring pre- and perinatal breastfeeding support via telehealth to more than 5,000 Connecticut families and newborns.
  • "As pediatric primary care providers, we know the short and long term medical and neurodevelopmental advantages of breastfeeding," said Dr. David M. Krol, MD, MPH, FAAP, medical director of Connecticut Children's Care Network.
  • "We are thrilled that Connecticut Children's Care Network has selected Nest Collaborative to help improve care for families with newborns throughout the state," said Amanda Gorman, CPNP, Founder and Chief Clinical Officer of Nest Collaborative.
  • Experts in human lactation, they can support families in their infant feeding decisions, including exclusive breastfeeding, supplementation, re-lactation, and return-to-work.

Sharpe Capital Partners With Connecticut Children's Through 2023

Retrieved on: 
Monday, October 3, 2022

WETHERSFIELD, Conn., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Sharpe Capitalis excited to announce they have extended their "Growing Businesses Building a Community" program, which benefits Connecticut Children's, through September 2023.

Key Points: 
  • WETHERSFIELD, Conn., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Sharpe Capitalis excited to announce they have extended their "Growing Businesses Building a Community" program, which benefits Connecticut Children's, through September 2023.
  • Sharpe Capital developed a co-marketing relationship with Connecticut Children's Foundation in 2017, pledging one percent of its total receivables or commissions to be used for the nonprofit's Greatest Need Children's Fund.
  • "We are grateful to Sharpe Capital for their generosity and continued support of the Greatest Need Children's Fund.
  • Connecticut Children's is the only health system in Connecticut dedicated to children, providing more than 30 pediatric specialties.

Enhabit Home Health & Hospice Completes Spin-off from Encompass Health

Retrieved on: 
Friday, July 1, 2022

DALLAS, July 1, 2022 /PRNewswire/ -- Enhabit Home Health & Hospice, a leading national home health and hospice provider, today announces it is now an independent, publicly traded company following the completion of its spin-off from Encompass Health Corporation. Enhabit will begin trading regular way on the New York Stock Exchange this morning, July 1, 2022, under the ticker symbol "EHAB."

Key Points: 
  • DALLAS, July 1, 2022 /PRNewswire/ -- Enhabit Home Health & Hospice, a leading national home health and hospice provider, today announces it is now an independent, publicly traded company following the completion of its spin-off from Encompass Health Corporation.
  • Enhabit has more than 20 years of proven expertise, growing into one of the largest providers of home health and hospice services nationally.
  • With over 10,000 employees at 351 locations in 34 states, Enhabit has an award-winning culture that is a key contributor to its continued success.
  • Enhabit Home Health & Hospice is a leading national home health and hospice provider working to expand what's possible for patient care in the home.

Governors Highway Safety Association, National Road Safety Foundation Award $75,000 in Grants to Three States for Safe Youth Active Mobility

Retrieved on: 
Thursday, March 3, 2022

WASHINGTON, March 3, 2022 /PRNewswire/ -- The Governors Highway Safety Association has awarded grants totaling $75,000 from the National Road Safety Foundation to State Highway Safety Offices in Connecticut, New York and Pennsylvania to work with community-based groups to promote safe youth mobility options like walking, biking or riding a scooter.

Key Points: 
  • WASHINGTON, March 3, 2022 /PRNewswire/ -- The Governors Highway Safety Association has awarded grants totaling $75,000 from the National Road Safety Foundation to State Highway Safety Offices in Connecticut, New York and Pennsylvania to work with community-based groups to promote safe youth mobility options like walking, biking or riding a scooter.
  • A grant in Hartford, Conn., will be used to recruit and train youth ambassadors to educate their peers about bicycle and pedestrian safety.
  • The Governors Highway Safety Association (GHSA) is a nonprofit association representing the highway safety offices of states, territories, the District of Columbia and Puerto Rico.
  • Its members are appointed by their Governors to administer federal and state highway safety funds and implement state highway safety plans.

New Paper Shows Biostage's Esophageal Implant Regenerates the Esophagus in Piglets

Retrieved on: 
Monday, January 10, 2022

The paper(1) was published today in Nature Partner Journals Regenerative Medicine and concludes that the Biostage Esophageal Implant, "is safe and well tolerated".

Key Points: 
  • The paper(1) was published today in Nature Partner Journals Regenerative Medicine and concludes that the Biostage Esophageal Implant, "is safe and well tolerated".
  • The piglets gained weight steadily over the course of the study and eventually tripled their size, showing that the regenerated esophagus grows with the patient.
  • The paper states that current techniques for repairing birth defects in the esophagus, "have significant costs, complication rates, lengthy hospital stays, and significant morbidities.
  • That paper concluded that the Biostage Esophageal Implant would have, "considerable clinical use."

Biostage Hires David Green as Chief Executive Officer

Retrieved on: 
Tuesday, November 30, 2021

HOLLISTON, Mass., Nov. 30, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company with successful "first-in-human" experience in esophageal cancer and FDA approval to commence a clinical trial of its Biostage Esophageal Implant for esophageal disease, today announced it has hired David Green as its Chief Executive Officer and appointed Mr. Green as Chairman of the Board of Directors (the "Board").

Key Points: 
  • HOLLISTON, Mass., Nov. 30, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company with successful "first-in-human" experience in esophageal cancer and FDA approval to commence a clinical trial of its Biostage Esophageal Implant for esophageal disease, today announced it has hired David Green as its Chief Executive Officer and appointed Mr. Green as Chairman of the Board of Directors (the "Board").
  • Mr. Green resigned from his roles in Biostage in 2015 after he had been involved in a major road accident.
  • The clinical results of the first-in-human use of our Biostage Esophageal Implant, conducted at Mayo Clinic in 2017, were very positive.
  • Because the Biostage Esophageal Implant is made using the patient's own cells, Biostage does not expect rejection of the implant.

Sharpe Capital Partners With Connecticut Children's Through 2022

Retrieved on: 
Thursday, September 30, 2021

NEWINGTON, Conn., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Sharpe Capitalis excited to announce they have extended their "Growing Businesses Building a Community" program, which benefits Connecticut Children's, through September 2022.

Key Points: 
  • NEWINGTON, Conn., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Sharpe Capitalis excited to announce they have extended their "Growing Businesses Building a Community" program, which benefits Connecticut Children's, through September 2022.
  • Sharpe Capital developed a co-marketing relationship with Connecticut Children's Foundation in 2017, pledging one percent of its total receivables or commissions to be used for the nonprofit's Greatest Need Children's Fund.
  • Connecticut Children's is the only health system in Connecticut dedicated exclusively to the care of children and ranked one of the best children's hospitals in the nation by U.S. News & World Report.
  • "We are grateful to Sharpe Capital for their generosity and continued support of the Greatest Need Children's Fund.